BAKER DOUGLAS P 4
4 · OptimizeRx Corp · Filed Aug 24, 2021
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
BAKER DOUGLAS P
Chief Financial Officer
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-08-24$61.50/sh−4,000$246,000→ 54,796 total - Sale
Common Stock (pursuant to 10B5-1 plan)
2021-08-20$58.45/sh−5,000$292,250→ 58,796 total
Footnotes (2)
- [F1]These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.